Diagnostics Equity Consortium

About

Diagnosis is a fundamental component of health care and surveillance, and a major driver of economic and health outcomes across health systems. Yet the importance of timely access to diagnostics remains underrecognized, causing diagnostics to be critically underfunded and the weakest link in the continuum of care. The Diagnostics Equity Consortium (DEC) strives to ensure sustained political and programmatic commitment to affordable, suitable, effective, and accessible diagnostics.

Our Work

The Diagnostics Equity Consortium — a partnership between the Center for Global Health Policy & Politics and the Pan-African Treatment Access Movement (PATAM) — generates analyses and engages government, civil society, global health actors, and industry in support of holistic diagnostics advocacy agenda. The consortium provides support for vigorous advocacy at the national level, while also facilitating and elevating the voice of affected communities and civil society on the global level with health actors, industry, and donors.

Featured Work

Universal Access to Healthcare: Diagnostics Equity Is at the Core

A Civil Society Vision for Strengthening Diagnostic Capacity for All

Publications

Publication

DEC Call to Action: Bring WRD Closer to Where People Live

23 October 2025 Delivered by Ida Savadogo, RAMEWritten by Sharonann Lynch, representatives from the Diagnostics Equity Consortium (DEC), and other civil society…

October 30, 2025

Submission to International Body

Close the Deadly TB Testing Gaps in Asia-Pacific: Civil Society Call to Action

April 14, 2025

Past Events